title: Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
abstract: Glutathione (GSH) is known to play a role in cellular sensitivity to some chemotherapeutic agents and to radiation. Depletion of cellular glutathione increases toxicity of these drugs, and this approach is being explored in the clinic as a form of biochemical modulation using the drug buthionine sulfoximine. The fact that some drug-resistant cell lines have increased GSH levels, and that enhancing glutathione concentrations in animal tissues protects against a variety of xenobiotic agents, suggests a different potential approach to improve anticancer therapy. We previously showed a selective enhancement by the cysteine "pro-drug," L-2-oxothiazolidine-4-carboxylate (OTZ), of GSH concentration in some normal tissues of tumor-bearing rats, whereas there is a paradoxic GSH depletion in tumor. OTZ has been shown to protect animals from a variety of toxins, and in vitro studies showed a selective increase in GSH in normal cells that results in reduced sensitivity to some chemotherapy drugs. This report describes evidence that OTZ provides this effect in an in vivo rat mammary tumor model. We have examined the OTZ "activating" enzyme, 5-oxoprolinase, in these tumors and found it to be 4-fold lower than that of normal rat liver. This may explain at least the lack of increased GSH in tumor in response to OTZ. A limited number of human breast cancer samples show similar activity.
authors.affiliation: Department of Oncology and Experimental Pharmacology Program, Lady Davis Research Institute, McGill University, Montreal, Canada.
authors.forename: T
authors.initials: T
authors.lastname: Wang
authors.forename: X
authors.initials: X
authors.lastname: Chen
authors.forename: R L
authors.initials: RL
authors.lastname: Schecter
authors.forename: S
authors.initials: S
authors.lastname: Baruchel
authors.forename: M
authors.initials: M
authors.lastname: Alaoui-Jamali
authors.forename: D
authors.initials: D
authors.lastname: Melnychuk
authors.forename: G
authors.initials: G
authors.lastname: Batist
mesh_terms: D000818:Animals; D002460:Cell Line; D003545:Cysteine / Q000494:pharmacology*; D004195:Disease Models, Animal; D005260:Female; D005978:Glutathione / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D011355:Prodrugs / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D011355:Prodrugs; D005978:Glutathione; D003545:Cysteine